Robert C. Green, MD, MPH
Fellow in Genetics/Professor of Neurology, Genetics, and Epidemiology
Harvard Medical School, Partners Center for Personalized Genetic Medicine/
Boston University Schools of Medicine and Public Health

Robert Green, MD, MPH, graduated from Amherst College and the University of Virginia School of Medicine before fulfilling a residency in neurology at Harvard Medical School’s Longwood Neurology Program. Following this, he completed research fellowships at the Beth Israel Hospital and Children’s Hospital in Boston, winning both the William B. Lennox Research Fellowship and the Wilder Penfield Research Fellowship. Robert obtained additional training in Epidemiology, receiving a master’s degree in Public Health from the Rollins School of Public Health at Emory University. In 1999, Dr. Green joined the faculty of Boston University, where he is currently Professor of Neurology, Genetics, and Epidemiology at Boston University Schools of Medicine and Public Health. He is also a Fellow in Genetics at Harvard Medical School and will be board-eligible in medical genetics at the end of 2010.

Robert’s research interests are in developing a national research agenda for translational genomics and personalized medicine. He has worked for over 20 years in the genetics of Alzheimer’s disease and is currently Principal Investigator and Director of the REVEAL (Risk Evaluation and Education for Alzheimer’s disease) Study, a multi-center project funded by the National Human Genome Research Institute to develop genetic risk assessment strategies for family members of patients with Alzheimer’s disease. This study is the first to use randomized clinical studies to explore the impact of genetic susceptibility testing and disclosure.

Robert serves on a number of advisory, editorial, and grant review boards, including the Health Services Genomics Panel for VA Health Services Research and the Translational Research Committee for Genes and Environment Initiative at NIH. He has been invited to participate in NIH planning workshops on the future of genomic medicine and has been a featured or plenary speaker on translational genomics and personalized medicine at meetings of the American Academy of Neurology, the National Coalition of Health Care Professionals for Education in Genetics, the World Congress on Psychiatric Genetics, the American Society for Human Genetics, the National Press Club, and the Bio IT World Conference.